These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31455451)

  • 21. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
    Murta SM; Romanha AJ
    Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
    Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
    Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
    Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
    Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
    Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG
    Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.
    Marins-Dos-Santos A; Olivieri BP; Ferreira-Reis R; de Meis J; Silva AA; de Araújo-Jorge TC; Lannes-Vieira J; Cotta-de-Almeida V
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008969. PubMed ID: 33347472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action.
    Milagre MM; Torchelsen FKVDS; Pedrosa TCF; Teixeira GM; Sampaio LS; Saúde-Guimarães DA; Branquinho RT; Mosqueira VCF; Lana M
    Exp Parasitol; 2023 Dec; 255():108647. PubMed ID: 37914151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.
    Andrade SG; Silva RC; Santiago CM; Freitas LA
    Bull World Health Organ; 1987; 65(5):625-33. PubMed ID: 3123082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.
    Bustamante JM; Craft JM; Crowe BD; Ketchie SA; Tarleton RL
    J Infect Dis; 2014 Jan; 209(1):150-62. PubMed ID: 23945371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fexinidazole: a potential new drug candidate for Chagas disease.
    Bahia MT; de Andrade IM; Martins TA; do Nascimento ÁF; Diniz Lde F; Caldas IS; Talvani A; Trunz BB; Torreele E; Ribeiro I
    PLoS Negl Trop Dis; 2012; 6(11):e1870. PubMed ID: 23133682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
    Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
    Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi.
    Michailowsky V; Murta SM; Carvalho-Oliveira L; Pereira ME; Ferreira LR; Brener Z; Romanha AJ; Gazzinelli RT
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2549-56. PubMed ID: 9756754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi.
    Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC
    ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
    Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.